New leads for drug repurposing against malaria

•Eighteen FDA approved drugs identified for repurposing as antimalarials.•Drugs classified based on safety of prescription to high-risk groups.•Identification of eleven drugs suitable for pediatric use.•Potential target matches identified for eight drugs in P. falciparum.•Fifteen drugs show potential for clinical trials to treat malaria.